Evidence map›Paper›PMID 26594624›Full record

ArticleNeuroImage. Clinical2015

Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study.

Christiane Möller, Anne Hafkemeijer, Yolande A L Pijnenburg, Serge A R B Rombouts, Jeroen van der Grond, Elise Dopper, John van Swieten, Adriaan Versteeg, Petra J W Pouwels, Frederik Barkhof and 3 more

Abstract readMulticenter Study
In one paragraph

Article in NeuroImage. Clinical, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Frontotemporal Dementia, Where Do We Stand? A Narrative Review.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christiane MöllerDepartment of Neurology & Alzheimer Center, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Anne HafkemeijerInstitute of Psychology, Leiden University, Leiden, The Netherlands ; Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.
Yolande A L PijnenburgDepartment of Neurology & Alzheimer Center, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Serge A R B RomboutsInstitute of Psychology, Leiden University, Leiden, The Netherlands ; Leiden Institute for Brain and Cognition, Leiden University, Leiden, The Netherlands.
Jeroen van der GrondDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
Elise DopperDepartment of Neurology & Alzheimer Center, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands ; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands ; Department of Clinical Genetics, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands ; Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
John van SwietenDepartment of Clinical Genetics, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands ; Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
Adriaan VersteegDepartment of Radiology & Nuclear Medicine, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Petra J W PouwelsDepartment of Physics & Medical Technology, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Frederik BarkhofDepartment of Radiology & Nuclear Medicine, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Philip ScheltensDepartment of Neurology & Alzheimer Center, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Hugo VrenkenDepartment of Radiology & Nuclear Medicine, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands ; Department of Physics & Medical Technology, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.
Wiesje M van der FlierDepartment of Neurology & Alzheimer Center, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands ; Department of Epidemiology & Biostatistics, Neuroscience Campus, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We investigated the ability of cortical and subcortical gray matter (GM) atrophy in combination with white matter (WM) integrity to distinguish behavioral variant frontotemporal dementia (bvFTD) from Alzheimer's disease (AD) and from controls using voxel-based morphometry, subcortical structure segmentation, and tract-based spatial statistics. To determine which combination of MR markers differentiated the three groups with the highest accuracy, we conducted discriminant function analyses. Adjusted for age, sex and center, both types of dementia had more GM atrophy, lower fractional anisotropy (FA) and higher mean (MD), axial (L1) and radial diffusivity (L23) values than controls. BvFTD patients had more GM atrophy in orbitofrontal and inferior frontal areas than AD patients. In addition, caudate nucleus and nucleus accumbens were smaller in bvFTD than in AD. FA values were lower; MD, L1 and L23 values were higher, especially in frontal areas of the brain for bvFTD compared to AD patients. The combination of cortical GM, hippocampal volume and WM integrity measurements, classified 97-100% of controls, 81-100% of AD and 67-75% of bvFTD patients correctly. Our results suggest that WM integrity measures add complementary information to measures of GM atrophy, thereby improving the classification between AD and bvFTD.

Indexed as

AgedAlzheimer DiseaseAtrophyBiomarkersCerebral CortexDiffusion Tensor ImagingFemaleFrontotemporal DementiaGray MatterHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsWhite MatterBiomarkersAlzheimer's diseaseDiagnosisDiscriminant analysesFrontotemporal dementiaGray matter atrophyWhite matter integrity

Identifiers

PMID26594624
PMCPMC4600847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.